For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Arcus Biosciences Inc (NYSE: RCUS) closed at $16.9 up 8.19% from its previous closing price of $15.62. In other words, the price has increased by $8.19 from its previous closing price. On the day, 1.97 million shares were traded. RCUS stock price reached its highest trading level at $16.93 during the session, while it also had its lowest trading level at $15.375.
Ratios:
For a deeper understanding of Arcus Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.50 and its Current Ratio is at 4.50. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on February 26, 2025, Upgraded its rating to Buy and sets its target price to $24 from $18 previously.
On October 21, 2024, H.C. Wainwright started tracking the stock assigning a Neutral rating and target price of $20.
On October 08, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $29.Wells Fargo initiated its Overweight rating on October 08, 2024, with a $29 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 08 ’25 when Jarrett Jennifer sold 37,792 shares for $15.05 per share. The transaction valued at 568,611 led to the insider holds 214,232 shares of the business.
Jarrett Jennifer sold 12,500 shares of RCUS for $181,801 on Oct 06 ’25. The Chief Operating Officer now owns 214,232 shares after completing the transaction at $14.54 per share. On Oct 06 ’25, another insider, Jennifer Jarrett, who serves as the Officer of the company, bought 100,583 shares for $13.35 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCUS now has a Market Capitalization of 1798683392 and an Enterprise Value of 1017683520. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.87 while its Price-to-Book (P/B) ratio in mrq is 3.28. Its current Enterprise Value per Revenue stands at 3.884 whereas that against EBITDA is -3.103.
Stock Price History:
The Beta on a monthly basis for RCUS is 0.85, which has changed by -0.14364034 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, RCUS has reached a high of $18.98, while it has fallen to a 52-week low of $6.50. The 50-Day Moving Average of the stock is 41.53%, while the 200-Day Moving Average is calculated to be 61.07%.
Shares Statistics:
For the past three months, RCUS has traded an average of 867.93K shares per day and 1271480 over the past ten days. A total of 106.40M shares are outstanding, with a floating share count of 65.32M. Insiders hold about 38.63% of the company’s shares, while institutions hold 62.52% stake in the company. Shares short for RCUS as of 1759190400 were 9891818 with a Short Ratio of 11.40, compared to 1756425600 on 9834666. Therefore, it implies a Short% of Shares Outstanding of 9891818 and a Short% of Float of 14.21.
